Trial
NCT05909995
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Incyte Corporation
Collaborators
—
Condition
Melanoma
Intervention
INCB 99280 with Ipilimumab
Why stopped
This was a strategic business decision. There were no safety concerns contributing to this decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-18